Lancet 377 (9771), 10851095
Key Takeaways PCOS creates a metabolic trap: insulin resistance drives weight gain, and weight gain worsens insulin resistance Tirzepatide's dual GIP/GLP-1 mechanism directly targets the insulin resistance at the core of PCOS Clinical trials show 15-22% body weight loss with tirzepatide, with particular benefits for insulin-resistant patients Benefits extend beyond the scale: improved androgen levels, restored ovulation, and reduced cardiovascular risk Tirzepatide may be more effective than semaglutide for PCOS due to its additional GIP receptor activity Table of Contents Have PCOS and Struggling to Lose Weight
Glycine Propionyl L-Carnitine This is also called GPLC
This printable kit helps you: Build a routine for GLP-1 nausea relief and recovery Choose low-fat, stomach-friendly meals that wont backfire Stay hydrated and gently nourished Modify family meals so youre not eating separately No more guessing
Both Nirchi and Long point to things like nausea and constipation, particularly when starting the drugs or titrating up to a higher dose (but for them, the benefits have outweighed the downsides)
Education has always been a big part of Sara's life and she considers herself to be a lifelong learner